Effects of Visually Scored Pleuroparenchymal Fibroelastosis Severity on Functional Decline and Mortality in IPF Patients
dc.authorid | Mogulkoc, Nesrin/0000-0003-1870-5669 | |
dc.authorid | Alexander, Daniel/0000-0003-2439-350X | |
dc.authorwosid | Mogulkoc, Nesrin/ABG-2839-2020 | |
dc.contributor.author | Gudmundsson, E. | |
dc.contributor.author | Zhao, A. | |
dc.contributor.author | Mogulkoc, N. | |
dc.contributor.author | Jones, M. G. | |
dc.contributor.author | Moorsel, C. V. | |
dc.contributor.author | Savas, R. | |
dc.contributor.author | Brereton, C. J. | |
dc.date.accessioned | 2023-01-12T20:19:44Z | |
dc.date.available | 2023-01-12T20:19:44Z | |
dc.date.issued | 2021 | |
dc.department | N/A/Department | en_US |
dc.description | International Conference of the American-Thoracic-Society (ATS) -- MAY 14-19, 2021 -- ELECTR NETWORK | en_US |
dc.description.abstract | [No Abstract Available] | en_US |
dc.description.sponsorship | Amer Thorac Soc | en_US |
dc.description.sponsorship | Wellcome Trust, London, UK; Biomedical Research Centre, UCL Hospitals, London, UK | en_US |
dc.description.sponsorship | Wellcome Trust, London, UK; Biomedical Research Centre, UCL Hospitals, London, UK | en_US |
dc.identifier.issn | 1073-449X | |
dc.identifier.issn | 1535-4970 | |
dc.identifier.issn | 1073-449X | en_US |
dc.identifier.issn | 1535-4970 | en_US |
dc.identifier.issue | 9 | en_US |
dc.identifier.uri | https://hdl.handle.net/11454/79205 | |
dc.identifier.volume | 203 | en_US |
dc.identifier.wos | WOS:000685468904629 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Amer Thoracic Soc | en_US |
dc.relation.ispartof | American Journal Of Respiratory And Critical Care Medicine | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Effects of Visually Scored Pleuroparenchymal Fibroelastosis Severity on Functional Decline and Mortality in IPF Patients | en_US |
dc.type | Conference Object | en_US |